3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase 1
4
Phase 2
2
Status
Active not recruiting
3
Recruiting
1
Sponsor Class
INDUSTRY
4
Study Type
Interventional
4
Sponsor
Cancer Type
Thoracic
4
Conditions
Small Cell Lung Carcinoma
4
Interventions
Carboplatin
283
Cisplatin
225
Pemetrexed
196
Paclitaxel
151
Docetaxel
132
pembrolizumab
109
Gemcitabine
94
Etoposide
64
Erlotinib Hydrochloride
59
Radiotherapy
54
Vinorelbine
47
durvalumab
46
Gefitinib
46
Bevacizumab
46
atezolizumab
42
Nivolumab
40
Drug Therapy
34
osimertinib
30
Topotecan
29
tislelizumab
23
130-nm albumin-bound paclitaxel
23
Radiosurgery
21
Ipilimumab
18
Crizotinib
18
Magnetic Resonance Spectroscopy
15
Albumin-Bound Paclitaxel
15
Surgical Procedures, Operative
14
aumolertinib
13
Platinum
13
Injections
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
AMG 757
×
Thoracic
×
Clear all
NCT07005128
2026-06-04
DeLLphi-312
Amgen
Phase 3
Recruiting
330 enrolled
NCT06117774
2026-04-29
DeLLphi-306
Amgen
Phase 3
Active not recruiting
404 enrolled
NCT05740566
2026-01-05
DeLLphi-304
Amgen
Phase 3
Active not recruiting
509 enrolled
11 charts
1 FDA
NCT06211036
2025-12-17
DeLLphi-305
Amgen
Phase 3
Active not recruiting
563 enrolled